Correlation Between SAB Biotherapeutics and ZyVersa Therapeutics
Can any of the company-specific risk be diversified away by investing in both SAB Biotherapeutics and ZyVersa Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SAB Biotherapeutics and ZyVersa Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SAB Biotherapeutics and ZyVersa Therapeutics, you can compare the effects of market volatilities on SAB Biotherapeutics and ZyVersa Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SAB Biotherapeutics with a short position of ZyVersa Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of SAB Biotherapeutics and ZyVersa Therapeutics.
Diversification Opportunities for SAB Biotherapeutics and ZyVersa Therapeutics
-0.72 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between SAB and ZyVersa is -0.72. Overlapping area represents the amount of risk that can be diversified away by holding SAB Biotherapeutics and ZyVersa Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ZyVersa Therapeutics and SAB Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SAB Biotherapeutics are associated (or correlated) with ZyVersa Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ZyVersa Therapeutics has no effect on the direction of SAB Biotherapeutics i.e., SAB Biotherapeutics and ZyVersa Therapeutics go up and down completely randomly.
Pair Corralation between SAB Biotherapeutics and ZyVersa Therapeutics
Assuming the 90 days horizon SAB Biotherapeutics is expected to generate 1.84 times more return on investment than ZyVersa Therapeutics. However, SAB Biotherapeutics is 1.84 times more volatile than ZyVersa Therapeutics. It trades about 0.18 of its potential returns per unit of risk. ZyVersa Therapeutics is currently generating about -0.15 per unit of risk. If you would invest 5.00 in SAB Biotherapeutics on August 27, 2024 and sell it today you would earn a total of 2.30 from holding SAB Biotherapeutics or generate 46.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 85.71% |
| Values | Daily Returns |
SAB Biotherapeutics vs. ZyVersa Therapeutics
Performance |
| Timeline |
| SAB Biotherapeutics |
| ZyVersa Therapeutics |
SAB Biotherapeutics and ZyVersa Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with SAB Biotherapeutics and ZyVersa Therapeutics
The main advantage of trading using opposite SAB Biotherapeutics and ZyVersa Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SAB Biotherapeutics position performs unexpectedly, ZyVersa Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ZyVersa Therapeutics will offset losses from the drop in ZyVersa Therapeutics' long position.| SAB Biotherapeutics vs. SAB Biotherapeutics | SAB Biotherapeutics vs. Jasper Therapeutics | SAB Biotherapeutics vs. NRx Pharmaceuticals |
| ZyVersa Therapeutics vs. Cns Pharmaceuticals | ZyVersa Therapeutics vs. Immix Biopharma | ZyVersa Therapeutics vs. Hepion Pharmaceuticals | ZyVersa Therapeutics vs. Zura Bio Limited |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |